Resources

Click on the links below to view Sovereign Pharma’s media coverages, press releases, and company brochure.

Brochure

PPT

Media

headline1

Budget 2021: Vaccine firms, ancillaries look at strong demand on govt’s ₹35,000-cr procurement plan.

Publication : LiveMint

Vaccine manufacturers and ancillaries are anticipating a strong demand from the government for Covid-19 vaccines alone after the government
announced its plans to procure ₹35,000 crore worth of jabs, an amount estimated to be enough to vaccinate roughly half of the country’s
population.

India’s largest vial maker expects sales to triple on COVID-19 vaccine ramp up

Publication : LiveMint

Year : May – 2021

Indian drug vial maker Schott Kaisha is expecting annual vial sales for
COVID-19 shots to more than triple as vaccine production, including by
one of its top customers Serum Institute, increases in response to a
monster second wave of infections.

Small
pharma firms shine during Covid

Publication : The Hindu Bussiness Line

Year : June – 2021

Over the last 15-odd months, the surge in demand for medicines to treat
Covid-19 has been intense and with life-and-death consequences for
patients.But navigating this ebb and flow in demand are a bunch of
rather low-profile companies.

Covid
vaccine glass tubing maker SCHOTT invest 70 mn euro in Gujarat plant

Publication : Business Standard

Year : Oct – 2021

Leading German specialty glass maker SCHOTT Glass India has announced an additional investment of 70 million euros to expand its Gujarat tubing plant that already makes FIOLAX glass used in Covid-19 vaccine packaging in India.

Kaisha
Packaging supplies seals for 2 B doses of COVID-19 vaccines globally

Publication : BioSpectrum India

Year : Dec – 2021

Pharma-packaging firm based in Mumbai, Kaisha Packaging has successfully
provided over 2 billion doses worth of flip-top aluminium seals used for
packaging COVID-19 vaccines.
The seal is used as a closure for injection vials during the vaccination
drive and is as such an essential part of the vaccine package ensuring
tamper-proof delivery.

Kaisha
Packaging supplies seals for Covid vaccines

Publication : Packaging SouthAsia

Year : Dec – 2021

Pharma-packaging firm based in Mumbai, Kaisha Packaging has successfully
provided over 2 billion doses worth of flip-top aluminium seals used for
packaging COVID-19 vaccines.
The seal is used as a closure for injection vials during the vaccination
drive and is as such an essential part of the vaccine package ensuring
tamper-proof delivery.

Daman-based Sovereign Pharma despatches first batch of Remdesivir for Cipla

Publication : Express Healthcare

Year : July – 2020

Vaccine manufacturers and ancillaries are anticipating a strong demand
from the government for Covid-19 vaccines alone after the government
announced its plans to procure ₹35,000 crore worth of jabs, an amount
estimated to be enough to vaccinate roughly half of the country’s
population.

Covid vaccine: Indian manufacturers flooded with orders from various countries for critical supply of syringes, vials

Publication : Financial Express

Year : Aug – 2020

With several countries joining the race for the Coronavirus vaccine, India has been getting several requests for the supply of ampoules, vials and syringes which play a critical role in administering the vaccine to the population on a mass level

Ancillary firms look to tap $6 billion vaccine business

Publication : LiveMint

Year : Sept – 2020

Makers of vials and syringes have started building up capacity in anticipation of a surge in demand if and when a successful covid-19 vaccine is launched in India—a market that could hit $6 billion.

World’s largest vaccine maker India tees up global blitz to contain virus

Publication : Business Standard

Year : Dec – 2020

India, the world’s biggest vaccine maker, is getting set for the massive global blitz to contain the coronavirus pandemic with its pharmaceutical industry and partners freeing up capacity and accelerating investments even without firm purchase ordersp>

Vial manufacturers prepare to ramp up capacity, govt still unclear on demand

Publication : The Indian Express

Year : Dec – 2020

With at least two Covid-19 vaccines closer to regulatory approvals and a couple of international candidates set to be manufactured in the country, makers of medical devices are ramping up capacity in anticipation of a potential surge in demand for vials and syringes.

Not without India. Pharma sector to play big role in vaccinating much of world

Publication : LiveMint

Year : Dec – 2020

India, the world’s biggest vaccine maker, is getting set for the massive global blitz to contain the coronavirus pandemic with its pharmaceutical industry and partners freeing up capacity and accelerating investments even without firm purchase orders.

First-of-its kind roadshow bringing customers, partners and prospects together

Publication : Packaging SouthAsia

Year : Feb – 2019

Vaccine manufacturers and ancillaries are anticipating a strong demand
from the government for Covid-19 vaccines alone after the government
announced its plans to procure ₹35,000 crore worth of jabs, an amount
estimated to be enough to vaccinate roughly half of the country’s
population.

KAISHA Introduces Pathbreaking Innovation With The Launch Of ‘KAISHA LIFESCIENCES’

Publication : Bussiness World

Year : sept – 2018

The three-decade old partnership of Kairus Dadachanji and Shapoorji Pallonji Mistry has resulted in yet another milestone in India’s pharmaceutical landscape with the birth of ‘KAISHA LIFESCIENCES’.

With multi-crore investment and a team of skilled pharma specialists committed to developing superior quality generic injectables and any other forms of medicine, KAISHA LIFESCIENCES is a privately-owned company